Published in Infect Immun on October 01, 2006
Lipid A modification systems in gram-negative bacteria. Annu Rev Biochem (2007) 8.60
Melioidosis vaccines: a systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposes. PLoS Negl Trop Dis (2012) 1.28
Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection. PLoS One (2009) 1.26
Structural biology of membrane-intrinsic beta-barrel enzymes: sentinels of the bacterial outer membrane. Biochim Biophys Acta (2007) 1.22
Recognition of lipid A variants by the TLR4-MD-2 receptor complex. Front Cell Infect Microbiol (2013) 1.14
Mining the Moraxella catarrhalis genome: identification of potential vaccine antigens expressed during human infection. Infect Immun (2008) 1.06
Contribution of Bordetella filamentous hemagglutinin and adenylate cyclase toxin to suppression and evasion of interleukin-17-mediated inflammation. Infect Immun (2012) 0.88
Identification of a novel lipopolysaccharide core biosynthesis gene cluster in Bordetella pertussis, and influence of core structure and lipid A glucosamine substitution on endotoxic activity. Infect Immun (2009) 0.87
Improved production process for native outer membrane vesicle vaccine against Neisseria meningitidis. PLoS One (2013) 0.83
Role of pagL and lpxO in Bordetella bronchiseptica lipid A biosynthesis. J Bacteriol (2011) 0.83
Structural characterization of Bordetella parapertussis lipid A. J Lipid Res (2008) 0.82
Coincorporation of LpxL1 and PagL mutant lipopolysaccharides into liposomes with Neisseria meningitidis opacity protein: influence on endotoxic and adjuvant activity. Clin Vaccine Immunol (2010) 0.82
Innate Immune Signaling Activated by MDR Bacteria in the Airway. Physiol Rev (2016) 0.81
Lipopolysaccharide engineering in Neisseria meningitidis: structural analysis of different pentaacyl lipid A mutants and comparison of their modified agonist properties. J Biol Chem (2014) 0.81
An improved whole cell pertussis vaccine with reduced content of endotoxin. Hum Vaccin Immunother (2013) 0.78
Bordetella pertussis naturally occurring isolates with altered lipooligosaccharide structure fail to fully mature human dendritic cells. Infect Immun (2014) 0.76
Meningococcal Outer Membrane Vesicle Composition-Dependent Activation of the Innate Immune Response. Infect Immun (2016) 0.75
The calcium-stimulated lipid A 3-O deacylase from Rhizobium etli is not essential for plant nodulation. Biochim Biophys Acta (2013) 0.75
Modulating endotoxin activity by combinatorial bioengineering of meningococcal lipopolysaccharide. Sci Rep (2016) 0.75
Proteobacteria explain significant functional variability in the human gut microbiome. Microbiome (2017) 0.75
Construction of Escherichia coli Mutant with Decreased Endotoxic Activity by Modifying Lipid A Structure. Mar Drugs (2015) 0.75
Studies on transformation of Escherichia coli with plasmids. J Mol Biol (1983) 116.81
A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem (1982) 36.39
Lipopolysaccharide endotoxins. Annu Rev Biochem (2001) 18.88
Molecular cloning of the plasmid RP4 primase region in a multi-host-range tacP expression vector. Gene (1986) 13.92
Release of lipopolysaccharide by EDTA treatment of E. coli. Biochem Biophys Res Commun (1965) 7.38
Analytical properties of the nanoelectrospray ion source. Anal Chem (1996) 7.12
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev (2005) 6.02
Biology of Bordetella bronchiseptica. Microbiol Rev (1980) 5.31
Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell (1998) 4.42
Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology (2004) 4.09
Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Immunol Methods (1990) 4.05
Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int J Cancer (1988) 3.66
Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation. Proc Natl Acad Sci U S A (2000) 3.03
Applications of cellular fatty acid analysis. Clin Microbiol Rev (1991) 2.72
Transfer of palmitate from phospholipids to lipid A in outer membranes of gram-negative bacteria. EMBO J (2000) 2.64
Phosphorelay control of virulence gene expression in Bordetella. Trends Microbiol (2003) 2.60
Meningitis bacterium is viable without endotoxin. Nature (1998) 2.52
Identification of an outer membrane protein required for the transport of lipopolysaccharide to the bacterial cell surface. Proc Natl Acad Sci U S A (2004) 2.43
IL-1 induction-capacity of defined lipopolysaccharide partial structures. J Immunol (1989) 2.41
The bvgAS locus negatively controls motility and synthesis of flagella in Bordetella bronchiseptica. J Bacteriol (1992) 2.33
A PhoP/PhoQ-induced Lipase (PagL) that catalyzes 3-O-deacylation of lipid A precursors in membranes of Salmonella typhimurium. J Biol Chem (2000) 2.32
Two physically and serologically distinct lipopolysaccharide profiles in strains of Bordetella pertussis and their phenotype variants. Infect Immun (1984) 2.30
Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect Immun (1997) 2.03
A mutation in the Bordetella bronchiseptica bvgS gene results in reduced virulence and increased resistance to starvation, and identifies a new class of Bvg-regulated antigens. Mol Microbiol (1997) 2.01
Biological activity, lipoprotein-binding behavior, and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides. J Clin Invest (1982) 2.01
Constitutive sensory transduction mutations in the Bordetella pertussis bvgS gene. J Bacteriol (1992) 1.91
Human Bordetella bronchiseptica infection related to contact with infected animals: persistence of bacteria in host. J Clin Microbiol (1995) 1.84
The ultimate localization of an outer membrane protein of Escherichia coli K-12 is not determined by the signal sequence. EMBO J (1983) 1.75
The identification, cloning and mutagenesis of a genetic locus required for lipopolysaccharide biosynthesis in Bordetella pertussis. Mol Microbiol (1996) 1.72
3-O-deacylation of lipid A by PagL, a PhoP/PhoQ-regulated deacylase of Salmonella typhimurium, modulates signaling through Toll-like receptor 4. J Biol Chem (2004) 1.67
Lipopolysaccharide transport to the bacterial outer membrane in spheroplasts. J Biol Chem (2004) 1.53
Lipid trafficking controls endotoxin acylation in outer membranes of Escherichia coli. J Biol Chem (2004) 1.50
Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by toll-like receptors 2 and 6. Infect Immun (2004) 1.49
Structural requirements of lipid A responsible for the functions: a study with chemically synthesized lipid A and its analogues. J Biochem (1985) 1.47
Biosynthesis, transport, and modification of lipid A. Biochem Cell Biol (2004) 1.40
Biochemical and functional characterization of membrane blebs purified from Neisseria meningitidis serogroup B. J Biol Chem (2005) 1.39
An outer membrane enzyme encoded by Salmonella typhimurium lpxR that removes the 3'-acyloxyacyl moiety of lipid A. J Biol Chem (2006) 1.39
Bordetella bronchiseptica PagP is a Bvg-regulated lipid A palmitoyl transferase that is required for persistent colonization of the mouse respiratory tract. Mol Microbiol (2003) 1.35
The virulence factors of Bordetella pertussis: a matter of control. FEMS Microbiol Rev (2001) 1.31
Structural and functional analyses of bacterial lipopolysaccharides. Microbes Infect (2002) 1.30
Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells. Infect Immun (2004) 1.25
Dissemination of lipid A deacylases (pagL) among gram-negative bacteria: identification of active-site histidine and serine residues. J Biol Chem (2004) 1.22
Pneumonia due to Bordetella bronchiseptica in a patient with AIDS. Rev Infect Dis (1991) 1.21
Expression cloning and biochemical characterization of a Rhizobium leguminosarum lipid A 1-phosphatase. J Biol Chem (2003) 1.19
Crystal structure and catalytic mechanism of the LPS 3-O-deacylase PagL from Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (2006) 1.15
Toll-like receptor 4 is critical to innate host defense in a murine model of bordetellosis. J Infect Dis (2004) 1.14
Toll-like receptor 4-dependent early elicited tumor necrosis factor alpha expression is critical for innate host defense against Bordetella bronchiseptica. Infect Immun (2004) 1.13
Lipopolysaccharide structure influences the macrophage response via CD14-independent and CD14-dependent pathways. Clin Infect Dis (1999) 1.11
Inhibition of Salmonella enterica serovar Typhimurium lipopolysaccharide deacylation by aminoarabinose membrane modification. J Bacteriol (2005) 1.08
Rational medium design for Bordetella pertussis: basic metabolism. J Biotechnol (1999) 1.06
Bordetella pertussis-specific Th1/Th2 cells generated following respiratory infection or immunization with an acellular vaccine: comparison of the T cell cytokine profiles in infants and mice. Dev Biol Stand (1997) 1.05
Biochemical and immunological comparison of lipopolysaccharides from Bordetella species. J Gen Microbiol (1990) 1.04
Host genetics of Bordetella pertussis infection in mice: significance of Toll-like receptor 4 in genetic susceptibility and pathobiology. Infect Immun (2006) 1.02
Biological properties of lipopolysaccharides from Bordetella species. J Gen Microbiol (1990) 1.02
Bordetella pertussis adenylate cyclase toxin modulates innate and adaptive immune responses: distinct roles for acylation and enzymatic activity in immunomodulation and cell death. J Immunol (2005) 1.00
Expression of foreign LpxA acyltransferases in Neisseria meningitidis results in modified lipid A with reduced toxicity and retained adjuvant activity. Cell Microbiol (2002) 0.97
Pneumonia caused by Bordetella bronchiseptica in a patient with a thoracic trauma. Infection (1991) 0.95
Structural characterization of the lipid A of Bordetella pertussis 1414 endotoxin. J Bacteriol (1994) 0.95
Expression and involvement of Toll-like receptors (TLR)2, TLR4, and CD14 in monocyte TNF-alpha production induced by lipopolysaccharides from Neisseria meningitidis. Med Sci Monit (2003) 0.89
Structural characterization of the lipids A of three Bordetella bronchiseptica strains: variability of fatty acid substitution. J Bacteriol (1997) 0.89
Interleukin-1 induction by lipopolysaccharides: structural requirements of the 3-deoxy-D-manno-2-octulosonic acid (KDO). Mol Immunol (1989) 0.85
Structural and biological characterization of highly purified hepta-acyl lipid A present in the lipopolysaccharide of the Salmonella enterica sv. Minnesota Re deep rough mutant strain R595. J Endotoxin Res (2002) 0.80
Acellular pertussis vaccines: the final countdown. Eur J Pediatr (1996) 0.76
Role of a highly conserved bacterial protein in outer membrane protein assembly. Science (2003) 4.78
Biogenesis of the gram-negative bacterial outer membrane. Annu Rev Microbiol (2007) 3.52
Structure of the translocator domain of a bacterial autotransporter. EMBO J (2004) 3.14
Assembly factor Omp85 recognizes its outer membrane protein substrates by a species-specific C-terminal motif. PLoS Biol (2006) 3.12
Identification of an outer membrane protein required for the transport of lipopolysaccharide to the bacterial cell surface. Proc Natl Acad Sci U S A (2004) 2.43
Biogenesis of beta-barrel membrane proteins in bacteria and eukaryotes: evolutionary conservation and divergence. Cell Mol Life Sci (2009) 1.62
A Neisserial autotransporter NalP modulating the processing of other autotransporters. Mol Microbiol (2003) 1.56
Crystal structure of Neisserial surface protein A (NspA), a conserved outer membrane protein with vaccine potential. J Biol Chem (2003) 1.54
Lipopolysaccharide transport to the bacterial outer membrane in spheroplasts. J Biol Chem (2004) 1.53
Omp85, an evolutionarily conserved bacterial protein involved in outer-membrane-protein assembly. Res Microbiol (2004) 1.47
Biogenesis of the Gram-negative bacterial outer membrane. Curr Opin Microbiol (2004) 1.47
Additive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of Neisseria meningitidis. Infect Immun (2007) 1.44
Signals in bacterial beta-barrel proteins are functional in eukaryotic cells for targeting to and assembly in mitochondria. Proc Natl Acad Sci U S A (2009) 1.40
Functioning of outer membrane protein assembly factor Omp85 requires a single POTRA domain. EMBO Rep (2007) 1.39
Interactions between phage-shock proteins in Escherichia coli. J Bacteriol (2003) 1.33
The beta-barrel outer membrane protein assembly complex of Neisseria meningitidis. J Bacteriol (2009) 1.30
Viability of a capsule- and lipopolysaccharide-deficient mutant of Neisseria meningitidis. Infect Immun (2005) 1.27
Cellular solid-state nuclear magnetic resonance spectroscopy. Proc Natl Acad Sci U S A (2012) 1.25
Solid-state NMR spectroscopy on cellular preparations enhanced by dynamic nuclear polarization. Angew Chem Int Ed Engl (2012) 1.25
Polar localization of the autotransporter family of large bacterial virulence proteins. J Bacteriol (2006) 1.24
Role of the pilot protein YscW in the biogenesis of the YscC secretin in Yersinia enterocolitica. J Bacteriol (2004) 1.24
The Omp85 protein of Neisseria meningitidis is required for lipid export to the outer membrane. EMBO J (2003) 1.23
Dissemination of lipid A deacylases (pagL) among gram-negative bacteria: identification of active-site histidine and serine residues. J Biol Chem (2004) 1.22
Structure and electrophysiological properties of the YscC secretin from the type III secretion system of Yersinia enterocolitica. J Bacteriol (2004) 1.22
An outer membrane receptor of Neisseria meningitidis involved in zinc acquisition with vaccine potential. PLoS Pathog (2010) 1.19
Protein secretion and secreted proteins in pathogenic Neisseriaceae. FEMS Microbiol Rev (2006) 1.19
Differential activation of human and mouse Toll-like receptor 4 by the adjuvant candidate LpxL1 of Neisseria meningitidis. Infect Immun (2008) 1.16
Three homologues, including two membrane-bound proteins, of the disulfide oxidoreductase DsbA in Neisseria meningitidis: effects on bacterial growth and biogenesis of functional type IV pili. J Biol Chem (2004) 1.16
Crystal structure and catalytic mechanism of the LPS 3-O-deacylase PagL from Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (2006) 1.15
Variation of Neisseria gonorrhoeae lipooligosaccharide directs dendritic cell-induced T helper responses. PLoS Pathog (2009) 1.12
Role of Pseudomonas putida tol-oprL gene products in uptake of solutes through the cytoplasmic membrane. J Bacteriol (2003) 1.11
The mitochondrial porin, VDAC, has retained the ability to be assembled in the bacterial outer membrane. Mol Biol Evol (2009) 1.09
Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process. Vaccine (2010) 1.09
Naturally occurring lipid A mutants in neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy. PLoS Pathog (2009) 1.08
Modeling Neisseria meningitidis metabolism: from genome to metabolic fluxes. Genome Biol (2007) 1.08
Neisseria meningitidis expressing lgtB lipopolysaccharide targets DC-SIGN and modulates dendritic cell function. Cell Microbiol (2006) 1.08
Autotransporter secretion: varying on a theme. Res Microbiol (2013) 1.07
Altered linkage of hydroxyacyl chains in lipid A of Campylobacter jejuni reduces TLR4 activation and antimicrobial resistance. J Biol Chem (2010) 1.07
Pseudomonas evades immune recognition of flagellin in both mammals and plants. PLoS Pathog (2011) 1.06
Identification of a novel Gsp-related pathway required for secretion of the manganese-oxidizing factor of Pseudomonas putida strain GB-1. Mol Microbiol (2003) 1.04
Role of the periplasmic chaperones Skp, SurA, and DegQ in outer membrane protein biogenesis in Neisseria meningitidis. J Bacteriol (2011) 1.04
Export of the pseudopilin XcpT of the Pseudomonas aeruginosa type II secretion system via the signal recognition particle-Sec pathway. J Bacteriol (2006) 1.04
NalP-mediated proteolytic release of lactoferrin-binding protein B from the meningococcal cell surface. Infect Immun (2010) 1.00
Immunogenicity and structural characterisation of an in vitro folded meningococcal siderophore receptor (FrpB, FetA). Microbes Infect (2006) 1.00
Shielding of immunogenic domains in Neisseria meningitidis FrpB (FetA) by the major variable region. Vaccine (2006) 1.00
Human dendritic cell activation by Neisseria meningitidis: phagocytosis depends on expression of lipooligosaccharide (LOS) by the bacteria and is required for optimal cytokine production. Cell Microbiol (2004) 0.99
A novel phase-variable autotransporter serine protease, AusI, of Neisseria meningitidis. Microbes Infect (2006) 0.97
Vaccine potential of the Neisseria meningitidis lactoferrin-binding proteins LbpA and LbpB. Vaccine (2006) 0.97
Expression of foreign LpxA acyltransferases in Neisseria meningitidis results in modified lipid A with reduced toxicity and retained adjuvant activity. Cell Microbiol (2002) 0.97
Domain exchange at the 3' end of the gene encoding the fratricide meningococcal two-partner secretion protein A. BMC Genomics (2013) 0.96
Lessons from an LPS-deficient Neisseria meningitidis mutant. J Endotoxin Res (2003) 0.96
Mapping the binding domains on meningococcal Opa proteins for CEACAM1 and CEA receptors. Mol Microbiol (2003) 0.96
Agonists of Toll-like receptors 3, 4, 7, and 9 are candidates for use as adjuvants in an outer membrane vaccine against Neisseria meningitidis serogroup B. Infect Immun (2007) 0.96
Involvement of three meningococcal surface-exposed proteins, the heparin-binding protein NhbA, the α-peptide of IgA protease and the autotransporter protease NalP, in initiation of biofilm formation. Mol Microbiol (2012) 0.96
A novel secondary acyl chain in the lipopolysaccharide of Bordetella pertussis required for efficient infection of human macrophages. J Biol Chem (2007) 0.95
Teasing apart structural determinants of 'toxicity' and 'adjuvanticity': implications for meningococcal vaccine development. J Endotoxin Res (2004) 0.95
TLR4-dependent adjuvant activity of Neisseria meningitidis lipid A. Vaccine (2007) 0.95
MsbA is not required for phospholipid transport in Neisseria meningitidis. J Biol Chem (2005) 0.95
The Pseudomonas aeruginosa patatin-like protein PlpD is the archetype of a novel Type V secretion system. Environ Microbiol (2010) 0.94
The LptD chaperone LptE is not directly involved in lipopolysaccharide transport in Neisseria meningitidis. J Biol Chem (2011) 0.94
Opa+ and Opa- isolates of Neisseria meningitidis and Neisseria gonorrhoeae induce sustained proliferative responses in human CD4+ T cells. Infect Immun (2009) 0.94
The presence of a helix breaker in the hydrophobic core of signal sequences of secretory proteins prevents recognition by the signal-recognition particle in Escherichia coli. Eur J Biochem (2002) 0.93
Differential effect of TLR2 and TLR4 on the immune response after immunization with a vaccine against Neisseria meningitidis or Bordetella pertussis. PLoS One (2010) 0.93
Function of neisserial outer membrane phospholipase a in autolysis and assessment of its vaccine potential. Infect Immun (2005) 0.93
Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains. Vaccine (2013) 0.93
Two-partner secretion systems of Neisseria meningitidis associated with invasive clonal complexes. Infect Immun (2008) 0.92
Identification of proteins of Neisseria meningitidis induced under iron-limiting conditions using the isobaric tandem mass tag (TMT) labeling approach. Proteomics (2009) 0.92
Zinc piracy as a mechanism of Neisseria meningitidis for evasion of nutritional immunity. PLoS Pathog (2013) 0.91
Structure of a membrane-based steric chaperone in complex with its lipase substrate. Nat Struct Mol Biol (2006) 0.90
Immunogenicity of peptide-vaccine candidates predicted by molecular dynamics simulations. J Mol Biol (2003) 0.90
Solid-state NMR on a large multidomain integral membrane protein: the outer membrane protein assembly factor BamA. J Am Chem Soc (2011) 0.90
Lipase-specific foldases. Chembiochem (2004) 0.90
Immunodominance in mouse and human CD4+ T-cell responses specific for the Bordetella pertussis virulence factor P.69 pertactin. Infect Immun (2008) 0.89
Antibody specificities and effect of meningococcal carriage in icelandic teenagers receiving the Norwegian serogroup B outer membrane vesicle vaccine. Infect Immun (2003) 0.89
Hexadecane and Tween 80 stimulate lipase production in Burkholderia glumae by different mechanisms. Appl Environ Microbiol (2007) 0.89
Antibiotic trapping by plasmid-encoded CMY-2 β-lactamase combined with reduced outer membrane permeability as a mechanism of carbapenem resistance in Escherichia coli. Antimicrob Agents Chemother (2013) 0.88
Conformational analysis of opacity proteins from Neisseria meningitidis. Eur J Biochem (2002) 0.88
Interaction domains in the Pseudomonas aeruginosa type II secretory apparatus component XcpS (GspF). Microbiology (2007) 0.88
Identification of a novel lipopolysaccharide core biosynthesis gene cluster in Bordetella pertussis, and influence of core structure and lipid A glucosamine substitution on endotoxic activity. Infect Immun (2009) 0.87
Involvement of lipooligosaccharides of Haemophilus influenzae and Neisseria meningitidis in defensin-enhanced bacterial adherence to epithelial cells. Microb Pathog (2003) 0.87